Literature DB >> 27217297

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?

Serenella Castelvecchio1, Lorenzo Menicanti1, Andrea Garatti1, Roberto Tramarin2, Marianna Volpe2, Alessandro Parolari3.   

Abstract

Patients affected by diabetes usually have extensive coronary artery disease. Coronary revascularization has a prominent role in the treatment of coronary artery disease in the expanding diabetic population. However, diabetic patients undergoing coronary artery bypass grafting or percutaneous coronary intervention experience worse outcomes than nondiabetic patients. Several studies comparing coronary artery bypass grafting vs percutaneous coronary intervention in subgroups of diabetic patients demonstrated a survival advantage and fewer repeat revascularization procedures with an initial surgical strategy. This review summarizes the current state of evidence comparing the effectiveness and safety of coronary artery bypass grafting and percutaneous coronary intervention in diabetic patients.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27217297     DOI: 10.1016/j.athoracsur.2016.02.081

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Long-Term (10-Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus.

Authors:  Kyusup Lee; Jung-Min Ahn; Yong-Hoon Yoon; Do-Yoon Kang; Seo-Young Park; Euihong Ko; Hanbit Park; Sang-Cheol Cho; Sangwoo Park; Tae Oh Kim; Pil Hyung Lee; Seung-Whan Lee; Seong-Wook Park; Duk-Woo Park; Seung-Jung Park
Journal:  J Am Heart Assoc       Date:  2020-04-20       Impact factor: 5.501

2.  Overexpression of scavenger receptor and infiltration of macrophage in epicardial adipose tissue of patients with ischemic heart disease and diabetes.

Authors:  Concepción Santiago-Fernández; Luis M Pérez-Belmonte; Mercedes Millán-Gómez; Inmaculada Moreno-Santos; Fernando Carrasco-Chinchilla; Amalio Ruiz-Salas; Luis Morcillo-Hidalgo; José M Melero; Lourdes Garrido-Sánchez; Manuel Jiménez-Navarro
Journal:  J Transl Med       Date:  2019-03-20       Impact factor: 5.531

3.  Two-year safety and efficacy of Indigenous Abluminus Sirolimus Eluting Stent. Does it differ amongst diabetics? - Data from en-ABLe- REGISTRY.

Authors:  Kamal Sharma; Sameer Dani; Devang Desai; Prathap Kumar; Nirav Bhalani; Apurva Vasavada; Rutvik Trivedi
Journal:  J Cardiovasc Thorac Res       Date:  2021-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.